Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).

MLA

Vasiljevski, Emily R., et al. “Evaluating Modified Diets and Dietary Supplement Therapies for Reducing Muscle Lipid Accumulation and Improving Muscle Function in Neurofibromatosis Type 1 (NF1).” PLoS ONE, vol. 15, no. 8, Aug. 2020, pp. 1–17. EBSCOhost, https://doi.org/10.1371/journal.pone.0237097.

APA

Vasiljevski, E. R., Houweling, P. J., Rupasinghe, T., Kaur, T., Summers, M. A., Roessner, U., Little, D. G., & Schindeler, A. (2020). Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1). PLoS ONE, 15(8), 1–17. https://doi.org/10.1371/journal.pone.0237097

Chicago

Vasiljevski, Emily R., Peter J. Houweling, Thusitha Rupasinghe, Tarneet Kaur, Matthew A. Summers, Ute Roessner, David G. Little, and Aaron Schindeler. 2020. “Evaluating Modified Diets and Dietary Supplement Therapies for Reducing Muscle Lipid Accumulation and Improving Muscle Function in Neurofibromatosis Type 1 (NF1).” PLoS ONE 15 (8): 1–17. doi:10.1371/journal.pone.0237097.